Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

ANXA1 signaling as a novel therapeutic target for the resolution of immune dysfunction in HIV

Aug. 11, 2016

NIH awards a new contract to the IAVI to advance AIDS vaccine development

Aug. 10, 2016

GeoVax awarded contract from NIH to further develop HIV vaccine

Aug. 3, 2016

Janssen files for approval of darunavir/cobicistat combination tablets in Japan

July 29, 2016

Novel bispecific immunoadhesin shows promise for HIV prevention and immunotherapy

July 26, 2016

Targeting Tat expression pathways may be useful for reactivation of latent HIV-1

July 26, 2016

EMA's CHMP adopts positive opinion on type II variation application for Gilead's Truvada

July 25, 2016

ABX-464 well tolerated in first study in HIV-infected patients, another under way

July 22, 2016

Heterodimeric interleukin-15 can reduce viral reservoirs in SIV-infected macaques

July 21, 2016

FDA approves Prezista expanded prescribing information

July 19, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...